Skip to main content

Intermediate/Advanced Colposcopy

Start: 30/05/2018 09:45
End: 31/05/2018 16:00

Location: RCOG
Programme: ~/link/eb50ad4d19174490963a9ef4ea6d70f2.aspx


Cervical cancer is the fourth most common malignancy in women worldwide. The UK national screening programme has been pivotal in reducing the incidence and number of deaths from this disease, with colposcopy playing an essential role in early pre-invasive diagnosis and treatment.

This course aims to cover the latest advances in the field including: the NHSCSP guidelines, the likely role of HPV testing in primary screening, an update on the HPV vaccination programme, quality assurance issues, difficult clinical management issues with interactive case presentations. Intraepithelial neoplasia of other areas of the lower genital tract will be covered.

This course is aimed at recently trained colposcopists keen to advance their knowledge and expertise as well as a refresher for those who have been practising in the field for quite some time especially for those wishing to gain re-certification. It is not suitable for those with little or no experience in the area of colposcopy.         

The Intermediate/Advanced Colposcopy Course is for colposcopists in training for their BSCCP certification and is educationally beneficial, although not mandatory, for those actively practicing colposcopy and is suitable for those wishing re-certification.

Learning Objectives

  • Understand management of complex cases
  • Manage MDT meetings
  • Understand the responsibilities of being a trainer
  • Be appraised of the latest changes to the screening programme
  • Be aware of future avenues of research relevant to the screening programme

Who Should Attend?

  • Staff doctors, Trust doctors and Associate Specialists Trainees
  • Consultant gynaecologists
  • Cytopathologists interested in cervical screening
  • Practicing colposcopists from both nursing and medical backgrounds
  • Specialist Registrars with colposcopy experience/ ATSM trainees with the RCOG
  • Trainees in their last year wanting to broaden their knowledge in advanced colposcopy
  • It is not suitable for those with no little or no experience in the area of colposcopy

Course Organiser

Mr Simon Leeson FRCOG, North Wales

Honorary Director of Conferences

Mr Nick Panay FRCOG, London

Honorary Deputy Director of Conferences

Mr Philip Toozs-Hobson FRCOG, Birmingham

Course fees

The registration fee (inclusive of online discount and VAT at 20%) for this event is:

  • Standard Rate: £550.00
  • RCOG/Member inc SAS Doctors Rate: £495.00
  • Trainee Rate: £440.00
  • Allied Healthcare Professional Rate: £370.00

How to book

  1. Sign into the RCOG website or create your account here – you need to be registered with the RCOG website to book on to an event
  2. Check that your card billing address is listed in ‘My account’ > ‘My details’ > ‘Addresses’, as you will need this in order to complete your booking
  3. Check that your details are correct in ‘My account’ > ‘My details’ > ‘Career stage’, as we will use this to calculate your registration fee
  4. Return to this page
  5. Scroll down to the bottom of the page to find the booking form, which will appear once you are logged in

Alternatively, you can book using the postal booking form although if you book using this method you will not receive the online discount.

If you would like your hospital or trust to be invoiced for your place, please read the events FAQs for further details.

For any queries regarding this event, please contact the Events team: 



Zilico (Gold sponsor)zilico

Stand EC1

Zilico was founded in 2006 following a successful research collaboration between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust to develop a more accurate means of diagnosis for cervical intraepithelial neoplasia (CIN). The company launched ZedScan, its flagship product in 2014 and the product is now in routine use within the NHS. The company is further driving its adoption in both mature healthcare markets and emerging economies.

ZedScan utilizes Electrical Impedance Spectroscopy (EIS) to provide a rapid, reliable and reproducible assessment of the underlying tissue, providing real-time and more accurate diagnostics, overcoming the subjectivity associated with colposcopy. EIS enables objective identification of normal, cancerous and pre-cancerous cells with measurements undertaken at the same time as colposcopy.

With the advent of primary HPV testing in the UK, colposcopy clinics will require a better way of assessing more visually challenging low-grade abnormalities. ZedScan is a non-optical diagnostic method providing real-time, semi quantitative results enabling better patient management.

Zilico has developed its patented Electrical Impedance Spectroscopy into a platform technology for cancer diagnosis and is expanding its product development into other clinical areas such as vulval, oral, anal, and assessing tissue margins during surgery.


DySiS (Bronze sponsor)dysis

Stand EC4

The DYSIS Colposcope with DYSISmap is the only adjunctive colposcopy technology recommended by NICE.    DYSIS uses a proprietary technology to create an adjunctive map of the cervix, that highlights areas of interest to a clinician and assists with appropriate biopsy site selection.

The unparalleled on-board SMARTtrack documentation system, allows the clinician to monitor cervical changes over time, reassure and educate patients, it provides dynamic teaching tools for trainee’s and transforms colposcopy MDT meetings.

DYSIS Medical Ltd has Headquarters in Edinburgh, and US offices in Tampa, FL. The company is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations. It aims to be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications.

You need to be logged in to the RCOG website to make an online booking. Please go to the log-in page.